VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis.
Low S, Wu H, Jerath K, Tibolla A, Fogal B, Conrad R, MacDougall M, Kerr S, Berger V, Dave R, Villalona J, Pantages L, Ahlberg J, Li H, Van Hoorick D, Ververken C, Broadwater J, Waterman A, Singh S, Kroe-Barrett R.
Low S, et al.
MAbs. 2020 Jan-Dec;12(1):1709322. doi: 10.1080/19420862.2019.1709322.
MAbs. 2020.
PMID: 31924119
Free PMC article.